skip to content
 

Professor Sir Alan Fersht FRS

Portrait of arf25

Our major research programme concerns the folding, stability and activity of proteins. We apply a broad multi-disciplinary approach that combines methods and ideas of molecular biology and physical-organic chemistry. We use techniques including protein engineering, DNA cloning, sequencing and mutagenesis, cell culture, gene and peptide synthesis, spectroscopy, rapid reaction techniques, multi-dimensional NMR (we have a 500, 600, 700 and an 800 MHz spectrometers) and x-ray protein crystallography.

Current major projects include: protein folding, misfolding and disease; drug discovery; and structure-activity relationships of proteins involved in cancer and disease.

Although now emeritus, I am still fully active in research with long term funding, including an MRC Programme Grant.

Publications

Structures of closed and open conformations of dimeric human ATM.
D Baretić, HK Pollard, DI Fisher, CM Johnson, B Santhanam, CM Truman, T Kouba, AR Fersht, C Phillips, RL Williams
– Sci Adv
(2017)
3,
e1700933
Multisite aggregation of p53 and implications for drug rescue
GZ Wang, AR Fersht
– Proceedings of the National Academy of Sciences of the United States of America
(2017)
114,
E2634
Multisite aggregation of p53 and implications for drug rescue
G Wang, AR Fersht
– Proceedings of the National Academy of Sciences of the United States of America
(2017)
114,
E2634
Design of a molecular support for cryo-EM structure determination.
TG Martin, TAM Bharat, AC Joerger, X-C Bai, F Praetorius, AR Fersht, H Dietz, SHW Scheres
– Proceedings of the National Academy of Sciences of the United States of America
(2016)
113,
E7456
2-Sulfonylpyrimidines: Mild alkylating agents with anticancer activity toward p53-compromised cells.
MR Bauer, AC Joerger, AR Fersht
– Proceedings of the National Academy of Sciences of the United States of America
(2016)
113,
E5271
An in silico algorithm for identifying stabilizing pockets in proteins: Test case, the Y220C mutant of the p53 tumor suppressor protein
D Bromley, MR Bauer, AR Fersht, V Daggett
– Protein Engineering Design and Selection
(2016)
29,
377
Harnessing Fluorine-Sulfur Contacts and Multipolar Interactions for the Design of p53 Mutant Y220C Rescue Drugs.
MR Bauer, RN Jones, MGJ Baud, R Wilcken, FM Boeckler, AR Fersht, AC Joerger, J Spencer
– ACS Chem Biol
(2016)
11,
2265
The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches.
AC Joerger, AR Fersht
– Annual Review of Biochemistry
(2016)
85,
375
Exploiting Transient Protein States for the Design of Small-Molecule Stabilizers of Mutant p53.
AC Joerger, MR Bauer, R Wilcken, MGJ Baud, H Harbrecht, TE Exner, FM Boeckler, J Spencer, AR Fersht
– Structure (London, England : 1993)
(2015)
23,
2246
Experimental and Theoretical Evaluation of the Ethynyl Moiety as a Halogen Bioisostere.
R Wilcken, MO Zimmermann, MR Bauer, TJ Rutherford, AR Fersht, AC Joerger, FM Boeckler
– ACS Chem Biol
(2015)
10,
2725
  •  
  • 1 of 63
  • >

Research Interest Group

Email address

arf25@cam.ac.uk